PP-090 Hepatitis B, C and D viruses in Tajikistan

  • Abdusamad D
Citations of this article
Mendeley users who have this article in their library.


Aim: To study was to investigate the genotypic prevalence and clinical significance of HCV, HBV, and/or HDV among chronic hepatitis patients with and without liver cirrhosis and/or HCC in Tajikistan. Methods: Sera were obtained from 124 consecutive cases of chronic liver diseases. Patients in this study were classified into two clinical groups: (i) chronic hepatitis and (ii) liver cirrhosis. Results: Genotypes of HBV, HCV, and HDV were determined by genetic sequencing. The overall prevalence of anti-HCV, HCV core antigen (HCVcAg) and HBsAg was 46{%} (57/124) and 41.1{%} (51/124), respectively. Co-infection of HCV/HBV, HBV/HDV, and HCV/HBV/HDV was found in 4.8{%} (6/124), 11.2{%} (12/124), and 0.8{%} (1/124) of cases, respectively. HDV genotype 1 was found in 19.6{%} (10/51) of HBsAgpositive patients. The HBV/HDV co-infection was relatively high in group 2 compared with group 1 (15{%} vs. 7.1{%}). HCV/1b was detected in 84.6{%} (44/52) of HCV RNA-positive patients, followed by 3a (7.6{%}), 2a (5.7{%}), and 2c (1.9{%}). HBV/D was detected in 94.1{%} (48/51) of HBsAg-positive patients, followed by HBV/A [5.8{%} (3/51)]. T1762/A1764 double mutation was associated with liver cirrhosis in HBVinfected patients (P = 0.0004). Conclusion: Among HBV-infected patients, the T1762/A1764 mutation was associated with liver cirrhosis.




Abdusamad, D. (2011). PP-090 Hepatitis B, C and D viruses in Tajikistan. International Journal of Infectious Diseases, 15, S70. https://doi.org/10.1016/s1201-9712(11)60242-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free